11-Piperazinyldibenzo[b,e][1,4]diazepine
|
- $17 - $3541
- Product name: 11-Piperazinyldibenzo[b,e][1,4]diazepine
- CAS: 56296-18-5
- MF: C17H18N4
- MW: 278.35
- EINECS:
- MDL Number:MFCD25121806
- Synonyms:11-Piperazinyldibenzo[b,e][1,4]diazepine;11-(1-Piperazinyl)-5H-dibenzo[b,e][1,4]diazepine;DREADD agonist 1;5H-Dibenzo[b,e][1,4]diazepine, 11-(1-piperazinyl)-;Muscarinic acetylcholine receptor,schizophrenia,mAChR,Inhibitor,muscarinic,disease,inhibit,DREADD agonist21,neurodegenerative,acetylcholine,DREADD agonist 21,DREADD,neuronal,hM3Dq,DREADD agonist-21,activation,receptors;11-(Piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine;DREADD Agonist 21, DREADD agonist;DREADD agonist 21, 10 mM in DMSO
55 prices
Selected condition:
Brand
- aablocks
- ACHEMBLOCK
- AK Scientific
- Arctom
- Biorbyt Ltd
- Biosynth
- Cayman Chemical
- Chemenu
- ChemScene
- Crysdot
- DC Chemicals
- Sigma-Aldrich
- Tocris
- TRC
Package
- 50
- 2mg
- 1mg
- 10
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 200mg
- 250MG
- 1mlx10mM(inDMSO)
- 1g
- 5 mg
- 25 mg
- Manufactureraablocks
- Product numberAA00ELYR
- Product descriptionDREADD agonist 21 ≥98%
- Packaging1mg
- Price$17
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00ELYR
- Product descriptionDREADD agonist 21 ≥98%
- Packaging5mg
- Price$26
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00ELYR
- Product descriptionDREADD agonist 21 ≥98%
- Packaging10mg
- Price$39
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00ELYR
- Product descriptionDREADD agonist 21 ≥98%
- Packaging25mg
- Price$60
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00ELYR
- Product descriptionDREADD agonist 21 ≥98%
- Packaging50mg
- Price$93
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00ELYR
- Product descriptionDREADD agonist 21 ≥98%
- Packaging100mg
- Price$138
- Updated2026-05-28
- Buy
- ManufacturerACHEMBLOCK
- Product numberZ238145
- Product descriptionDREADD agonist 21 98%
- Packaging100MG
- Price$115
- Updated2026-05-27
- Buy
- ManufacturerACHEMBLOCK
- Product numberZ238145
- Product descriptionDREADD agonist 21 98%
- Packaging250MG
- Price$230
- Updated2026-05-27
- Buy
- ManufacturerAK Scientific
- Product number1046CT
- Product descriptionDREADDagonist21
- Packaging5mg
- Price$245
- Updated2021-12-16
- Buy
- ManufacturerArctom
- Product numberSLK-S0457
- Product descriptionDREADD agonist 21 99.80%
- Packaging5mg
- Price$140
- Updated2026-05-26
- Buy
- ManufacturerArctom
- Product numberSLK-S0457
- Product descriptionDREADD agonist 21 99.80%
- Packaging25mg
- Price$352
- Updated2026-05-26
- Buy
- ManufacturerArctom
- Product numberSLK-S0457
- Product descriptionDREADD agonist 21 99.80%
- Packaging1g
- Price$3541
- Updated2026-05-26
- Buy
- ManufacturerArctom
- Product numberSLK-S0457
- Product descriptionDREADD agonist 21 99.80%
- Packaging100mg
- Price$732
- Updated2026-05-26
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb1940797
- Product descriptionDREADD agonist 21 >98%(HPLC)
- Packaging100mg
- Price$770
- Updated2026-05-06
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb611255
- Product descriptionDREADD Agonist 21 >98%
- Packaging100mg
- Price$690.2
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb611255
- Product descriptionDREADD Agonist 21 >98%
- Packaging250mg
- Price$1179.8
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA00ELYR | DREADD agonist 21 ≥98% | 1mg | $17 | 2026-05-28 | Buy |
| aablocks | AA00ELYR | DREADD agonist 21 ≥98% | 5mg | $26 | 2026-05-28 | Buy |
| aablocks | AA00ELYR | DREADD agonist 21 ≥98% | 10mg | $39 | 2026-05-28 | Buy |
| aablocks | AA00ELYR | DREADD agonist 21 ≥98% | 25mg | $60 | 2026-05-28 | Buy |
| aablocks | AA00ELYR | DREADD agonist 21 ≥98% | 50mg | $93 | 2026-05-28 | Buy |
| aablocks | AA00ELYR | DREADD agonist 21 ≥98% | 100mg | $138 | 2026-05-28 | Buy |
| ACHEMBLOCK | Z238145 | DREADD agonist 21 98% | 100MG | $115 | 2026-05-27 | Buy |
| ACHEMBLOCK | Z238145 | DREADD agonist 21 98% | 250MG | $230 | 2026-05-27 | Buy |
| AK Scientific | 1046CT | DREADDagonist21 | 5mg | $245 | 2021-12-16 | Buy |
| Arctom | SLK-S0457 | DREADD agonist 21 99.80% | 5mg | $140 | 2026-05-26 | Buy |
| Arctom | SLK-S0457 | DREADD agonist 21 99.80% | 25mg | $352 | 2026-05-26 | Buy |
| Arctom | SLK-S0457 | DREADD agonist 21 99.80% | 1g | $3541 | 2026-05-26 | Buy |
| Arctom | SLK-S0457 | DREADD agonist 21 99.80% | 100mg | $732 | 2026-05-26 | Buy |
| Biorbyt Ltd | orb1940797 | DREADD agonist 21 >98%(HPLC) | 100mg | $770 | 2026-05-06 | Buy |
| Biorbyt Ltd | orb611255 | DREADD Agonist 21 >98% | 100mg | $690.2 | 2021-12-16 | Buy |
| Biorbyt Ltd | orb611255 | DREADD Agonist 21 >98% | 250mg | $1179.8 | 2021-12-16 | Buy |
Properties
Melting point :230-234 °C(Solvent: Methanol)
Boiling point :470.1±55.0 °C(Predicted)
Density :1.28±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMSO:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);1.8(Max Conc. mM)
Ethanol:29.61(Max Conc. mg/mL);106.39(Max Conc. mM) form :A crystalline solid
pka :8.56±0.10(Predicted)
color :Yellow
Water Solubility :H2O: 2mg/mL, clear
InChI :1S/C17H18N4/c1-2-6-14-13(5-1)17(21-11-9-18-10-12-21)20-16-8-4-3-7-15(16)19-14/h1-8,18-19H,9-12H2
InChIKey :JCBYXNSOLUVGTF-UHFFFAOYSA-N
SMILES :C1(C=CC=C2)=C2C(N3CCNCC3)=NC(C=CC=C4)=C4N1
Boiling point :470.1±55.0 °C(Predicted)
Density :1.28±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMSO:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);1.8(Max Conc. mM)
Ethanol:29.61(Max Conc. mg/mL);106.39(Max Conc. mM) form :A crystalline solid
pka :8.56±0.10(Predicted)
color :Yellow
Water Solubility :H2O: 2mg/mL, clear
InChI :1S/C17H18N4/c1-2-6-14-13(5-1)17(21-11-9-18-10-12-21)20-16-8-4-3-7-15(16)19-14/h1-8,18-19H,9-12H2
InChIKey :JCBYXNSOLUVGTF-UHFFFAOYSA-N
SMILES :C1(C=CC=C2)=C2C(N3CCNCC3)=NC(C=CC=C4)=C4N1
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
DREADD agonist 21 activates hM3Dq (EC50 = 1.7 nM), a designer receptor exclusively activated by designer drugs (DREADD) derived from the human muscarinic acetylcholine M3 receptor. It does not agonize the hM3 receptor and displays relatively weaker binding affinities for serotonin 5HT2A, 5HT2C, α1A-adrenergic, and histamine H1 receptors (Kis = 66, 170, 280, and 6 nM, respectively).More related product prices
Orexin 2 Receptor Agonist a-cyclohexyl-N-[1-[1-oxo-3-(3-pyridinyl)propyl]-4-piperidinyl]-benzeneacetamide



